학술논문

Prognostic Significance of CD30 Expression and Response to Brentuximab Vedotin in Patients with Angioimmunoblastic T Cell Lymphoma
Document Type
Journal
Source
BLOOD; NOV 2 2023, 142 5p. Supplement: 1
Subject
Language
English
ISSN
15280020